20 September 2018

Interview with Arne Bolch: “Luxembourg funds – innovative and reliable”

With roughly €4.2 trillion assets under management, approximately 300 management companies/AIFMs selling 70% of European OGAW funds within the EU and in places as far away as Chile and Japan, the Grand Duchy provides today a proven safe environment for investing in funds. Luxembourg funds are “tried and tested”; buying a Sicav is something many institutional investors have grown familiar with. How did this develop, how does Luxembourg maintain its leading position?

https://paperjam.lu/article/news-luxembourg-funds-innovative-and-reliable

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 11.09.2023

    GSK Update: Application of the law on a national screening mechanism for foreign direct investments in Luxembourg

    Read more
  • 17.07.2023

    GSK Update: Bill of Law: Modernising the Luxembourg Investment Funds Toolbox

    Read more
  • 06.04.2023

    GSK Update: Bill of Law: Modernising the Luxembourg Investment Funds Toolbox

    Read more
© GSK Stockmann 2023